Maria Fardis
2018
In 2018, Maria Fardis earned a total compensation of $9.4M as President and Chief Executive Officer at Lion Biotechnologies, a 1,005% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $510,000 |
|---|---|
| Option Awards | $8,284,600 |
| Salary | $600,000 |
| Total | $9,394,600 |
Fardis received $8.3M in option awards, accounting for 88% of the total pay in 2018.
Fardis also received $510K in non-equity incentive plan and $600K in salary.
Rankings
In 2018, Maria Fardis' compensation ranked 766th out of 14,244 executives tracked by ExecPay. In other words, Fardis earned more than 94.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 766 out of 14,244 | 95th |
Division Manufacturing | 252 out of 5,759 | 96th |
Major group Chemicals And Allied Products | 73 out of 2,122 | 97th |
Industry group Drugs | 56 out of 1,811 | 97th |
Industry Biological Products, Except Diagnostic Substances | 16 out of 339 | 95th |
Pay ratio
| Maria Fardis' Pay | $9,394,600 |
|---|---|
| Median Employee's Pay | $312,125 |
| Pay Ratio | 30to 1 |
In 2018, the annual total compensation of Maria Fardis was $9,394,600.
The annual total compensation of the median employee at Lion Biotechnologies was $312,125.
The ratio of Maria Fardis' pay to the pay of median employee was therefore 30 to one.
Source: SEC filing on April 29, 2019.
Fardis' colleagues
We found two more compensation records of executives who worked with Maria Fardis at Lion Biotechnologies in 2018.